Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
05/1995
05/31/1995CN1102993A Method for making Chinese medicine herbs preparation by polyenzyme system
05/30/1995US5420339 Alpha-aryl or heteroaryl-substituted amide ester ACAT inhibitors
05/30/1995US5420333 Lignan analogues, methods of preparation thereof and anti-hyperlipemic agents
05/30/1995US5420296 Angiogenesis inhibitors and cardiovascular disorders
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420247 Genetic engineering and expression vectors
05/30/1995US5420146 Di-oxadiazolidine derivatives as antihyperglycemic agents
05/30/1995US5420132 Substituted benzodioxins
05/30/1995US5420121 Use of 4-cholesten-3-one as an anti-obesity agent
05/30/1995CA2016326C Pyrido-pyridazinone acetic acids for treating chronic diabetic complications
05/30/1995CA1335733C 1h-indazole-3-acetic acids as aldose reductase inhibitors
05/26/1995WO1995013824A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995WO1995013805A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995WO1995013797A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/26/1995CA2176747A1 Use of nitric oxide synthase inhibitors in the treatment of autoimmune diseases
05/26/1995CA2176709A1 Method of treating renal disease by administering igf-i and igfbp-3
05/26/1995CA2175350A1 Interdigitation-fusion liposomes containing arachidonic acid metabolites
05/24/1995EP0654042A1 Amylin muteins
05/24/1995EP0630238A4 Reducing post-prandial fluctuations in plasma concentrations of large neutral amino acids (lnaa).
05/24/1995CN1028531C 2-oxa-1-oxo-8-azaspiro ¾4,5 decane derivatives, pharmaceutical compositions containing them and process for preparing same
05/24/1995CN1028521C Therapeutic agents
05/23/1995US5418243 Anticholesterol agents
05/23/1995US5418239 Acylcoenzyme a:cholesterol acyltransferase inhibitors
05/23/1995US5418227 For treatment of estrogen deficiency symptoms
05/23/1995US5418157 Recombinant 68,000 dalton collagenase of Clostridium histolyticum
05/23/1995CA2048613C Lipid absorption inhibitory composition
05/23/1995CA1335624C Synthetic aluminum silicate preparation
05/18/1995WO1995013365A1 Generation of high titers of recombinant aav vectors
05/18/1995WO1995013302A1 Cathepsin-l-specific inhibitor polypeptide
05/18/1995WO1995013296A1 Receptor specific atrial natriuretic peptides
05/18/1995WO1995013277A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995WO1995013262A1 Substituted phenyl compounds
05/18/1995WO1995013071A2 Treatment of immunoregulatory disorders
05/18/1995WO1995013061A1 Pharmaceutical compositions for prevention and treatment of cancerous disease and process for their preparation
05/18/1995WO1995013059A1 Farnesyl derivatives and pharmaceutical compositions containing them
05/18/1995WO1995012991A1 New beverage
05/18/1995CA2176363A1 Substituted phenyl compounds
05/18/1995CA2176134A1 New beverage
05/18/1995CA2176013A1 Treatment of immunoregulatory disorders
05/18/1995CA2175897A1 6-oxo-nucleosides useful as immunosuppressants
05/18/1995CA2151059A1 Cathepsin-l-specific inhibitor polypeptide
05/17/1995EP0652864A1 Hydroxamic acid derivatives and their use as anti-inflammatory compounds
05/17/1995EP0652749A1 METHODS AND COMPOSITIONS FOR INHIBITING 5$g(a)-REDUCTASE ACTIVITY
05/17/1995EP0506792B1 Insulin preparations containing nicotinic acid or nicotinamide
05/17/1995EP0484446B1 Carnitine supplemented finishing pig diet
05/17/1995CA2135711A1 Cyclic amino acid derivatives
05/16/1995US5416117 Cyclopropenone derivatives
05/16/1995US5416077 Physical stability improvement of liquid nutritional products
05/16/1995CA1335570C Silicon compounds in bone treatment
05/11/1995WO1995012611A1 Endothelin receptor antagonists
05/11/1995WO1995012598A1 Benzo-fused macrocycles promote release of growth hormone
05/11/1995WO1995012581A1 Pseudodipeptide product having an imidazole grouping and applications
05/11/1995WO1995012572A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/11/1995WO1995012417A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995WO1995012402A1 Estrogen compositions and method for neuroprotection
05/11/1995WO1995012394A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995WO1995007697A3 Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus
05/11/1995CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2175795A1 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists
05/11/1995CA2175467A1 Use of nitric oxide releasing compounds as protective agents in ischemia reperfusion injury
05/11/1995CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations
05/11/1995CA2174235A1 Benzo-fused macrocycles promote release of growth hormone
05/11/1995CA2173875A1 Endothelin receptor antagonists
05/11/1995CA2152822A1 Cyclobutane derivatives as inhibitors of squalene synthetase and protein farnesyltransferase
05/10/1995EP0652217A1 N-substituted imidazole derivatives
05/10/1995EP0652214A1 N-Aryl-2-cyano-3-hydroxy propenamide derivatives, a method for their preparation, their use as medicaments and pharmaceutical compositions containing them
05/10/1995EP0652006A1 Use of 2-phenyl-3-aryl-dihychobenzopyrans for lowering serum cholesterol
05/10/1995EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis
05/10/1995EP0651757A1 Novel acyclic amidine-group-containing diphosphonic acid derivatives, process for producing them and medicaments containing these compounds.
05/10/1995EP0651651A1 Amylin antagonists and agonists
05/10/1995EP0651642A1 Use of 1,3-dicyclopropymethyl-8-amino-xanthine for the treatment and prevention of type ii diabetes mellitus and obesity
05/10/1995CN1028368C Process for preparing nojirimycin derivatives
05/09/1995US5414068 Crosslinked anion exchange particles and method for producing the particles
05/09/1995US5413997 Triphenylmethane derivatives
05/09/1995CA2134251A1 N-substituted imidazole derivatives
05/09/1995CA2050293C Acat enzyme inhibitory composition
05/06/1995CA2134827A1 Methods for lowering serum cholesterol
05/05/1995CA2135044A1 N-aryl-2-cyano-3-hydroxypropenamides derivatives, proc ess for their preparation, their application as medicaments and pharmaceutical compositions containing them
05/04/1995WO1995011904A1 Novel a1 adenosine receptor agonists and antiagonists
05/04/1995WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995WO1995011690A1 Desferrioxamine oral delivery system
05/04/1995CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation
05/04/1995CA2134950A1 Method and compositions for stimulating intracellular glutathione
05/03/1995EP0650961A1 Substituted heterocyclic carboxylic acid amides, their preparation, and their use as medicaments
05/03/1995EP0650960A1 Substituted heterocyclic carboxylic acid amide esters, their preparation and their us as medicaments
05/03/1995EP0650953A1 Cyclised analogs of metabolites of fatty acids, process for their preparation and pharmaceutical compositions containing them
05/03/1995EP0650725A1 Compositions containing salts of L-2-oxothiazolidine-4-carboxylic acid and their use for stimulating intracellular glutathione
05/03/1995EP0650596A1 Compositions and methods for regulating cellular signal transducing systems
05/03/1995EP0650480A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines
05/03/1995EP0650474A1 Novel piperidyl amides, sulfonamides and sulfoxamides as inhibitors of cholesterol biosynthesis
05/03/1995EP0650361A1 Compositions for the treatment of arthritis containing phosphonates and nsaids
05/03/1995CN1102185A Substituted thiacycloalkeno |3,2-b¨ pyridines, methods of preparation, compositions and method of use
05/03/1995CA2134866A1 Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
05/03/1995CA2134865A1 Substituted heterocyclic carboxamide esters, their preparation and their use as pharmaceuticals
05/02/1995US5411956 Lipolytic enzyme inhibitors
05/02/1995CA1335451C Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
04/1995
04/29/1995CA2134536A1 Cyclized analogues of fatty acid, process for their preparation and pharmaceutical compositions containing them
04/27/1995WO1995011303A1 Cntf family antagonists
1 ... 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 1217 1218 1219 1220 1221 1222 1223 1224 ... 1298